A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight but beyond this, their weight regain plateaus, with individuals managing to keep off 25% of the weight lost to treatment, say researchers at the University of Cambridge
Compared with placebo, GLP-1s increase risk of nausea, vomiting, burping, constipation, diarrhea, GERD, and dyspepsia (indigestion)
Cc triu chng c th gim thiu m ch em c th c hng li nh: Gim au bng kinh Gim cng tc ngc Ci thin tm trng Gim cc triu chng mt mi Ginkgo Biloba c th l mt la chn b sung gim thiu cc triu chng PMS
And Eli Lilly researchers are conducting clinical trials for the newest GLP-1 drug, called retatrutide, which could help patients lose as much as 30% of their body weight